Department of Neurology, College of Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
Department of Neurology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul, 137-701, South Korea.
Neurol Sci. 2018 Sep;39(9):1579-1584. doi: 10.1007/s10072-018-3468-1. Epub 2018 Jun 16.
Hemorrhagic transformation (HT) is one of the most feared complications of acute recanalization therapies. The aim of this study was to evaluate whether blood-brain barrier permeability (BBBP) imaging can predict HT in the setting of acute recanalization therapy and to determine the sensitivity and specificity of BBBP for the prediction of HT according to the type of reperfusion therapy. We assessed a total of 46 patients who received recanalization therapy (intravenous (IV) recombinant tissue plasminogen activator (tPA), mechanical thrombectomy with a stent retriever or both) for acute ischemic stroke within the internal carotid artery or middle cerebral artery. BBBP above the threshold was significantly associated with HT after adjustment for confounding factors in all patients (OR 45.4, 95% CI 2.9~711.2, p = 0.007), patients who received IV tPA (OR 20.1, 95% CI 1.2-336.7, p = 0.037), and patients who received endovascular therapy (OR 47.2, 95% CI 1.9-1252.5, p = 0.022). The sensitivity and specificity of the initial BBBP measurement as a predictor of HT in the overall 46 patients were 80 and 71%, respectively. These values were 75 and 64% in only IV tPA group, 100 and 80% in only endovascular group, 77 and 67% in IV tPA with or without endovascular therapy group, and 86 and 76% in endovascular therapy with or without bridging IV tPA therapy group. Increased pretreatment BBBP values were significantly associated with HT after acute recanalization therapy. This correlation with HT was stronger in patients receiving endovascular mechanical thrombectomy than in patients receiving IV rtPA.
出血转化(HT)是急性再通治疗中最令人担忧的并发症之一。本研究旨在评估血脑屏障通透性(BBBP)成像是否可以预测急性再通治疗中的 HT,并根据再通治疗类型确定 BBBP 预测 HT 的敏感性和特异性。我们评估了 46 例接受急性颈内动脉或大脑中动脉缺血性卒中再通治疗(静脉注射(IV)重组组织型纤溶酶原激活剂(tPA)、支架取栓机械血栓切除术或两者联合)的患者。在调整混杂因素后,所有患者 BBBP 高于阈值与 HT 显著相关(OR 45.4,95%CI 2.9~711.2,p=0.007),接受 IV tPA 治疗的患者(OR 20.1,95%CI 1.2-336.7,p=0.037),以及接受血管内治疗的患者(OR 47.2,95%CI 1.9-1252.5,p=0.022)。46 例患者中,初始 BBBP 测量作为 HT 预测因子的敏感性和特异性分别为 80%和 71%。仅 IV tPA 组为 75%和 64%,仅血管内组为 100%和 80%,IV tPA 联合或不联合血管内治疗组为 77%和 67%,血管内治疗联合或不联合桥接 IV tPA 治疗组为 86%和 76%。急性再通治疗后,预处理 BBBP 值升高与 HT 显著相关。与接受 IV rtPA 治疗的患者相比,接受血管内机械血栓切除术的患者与 HT 的相关性更强。